Recently, the General Office of the State Council issued the “Guiding Opinions on Maintaining the Price and Supply of Shortage Medicines.” The “Guiding Opinion” stipulated that a national multi-source information collection platform for shortage medicines and a monitoring system for this platform should be established to realise information sharing of APIs (Active Pharmaceutical Ingredient) and pharmaceutical preparations in terms of their registration, production, procurement, and price. As for the drugs in the shortages list, pharmaceutical enterprises are allowed to quote their price on the provincial-level centralised drug procurement platform or on the internet so that medical institutions can purchase them on demand.
国办：强化药品价格常态化监管 完善短缺药品供应体系
来源：医药网 2019.10.14
近日，国务院办公厅印发《关于进一步做好短缺药品保供稳价工作的意见》（以下简称《意见》）。《意见》指出，应建立国家短缺药品多源信息采集平台和协同监测机制，实现原料药和制剂在注册、生产、采购、价格等方面的信息联通共享；对于短缺药品清单中的品种，允许企业在省级药品集中采购平台上自主报价、直接挂网，医疗机构自主采购。
Leave a Reply